MS Christian

get the facts about ms

Thursday, Sep 09th

Last update:14:00:09 CST

Headlines:
Causes of death among patients with multiple scler...
Risk perception in natalizumab-treated multiple sc...
Oral laquinimod in patients with relapsing-remitti...
New treatment for multiple sclerosis
Lindsay's an author once again ... 32 years after ...
Plasma gelsolin modulates cellular response to sph...
Sign up for Cycle India, join us for this exhilara...
Cladribine tablets approved in Australia
Friends of man who went to Dignitas clinic wait to...
MS Society spends £35 million in 2009 supportin...
British schools chief Michael Gove gets his sums w...
Court Denies Sandoz/Momenta's Summary Judgment of ...
Mum revitalised by pioneering MS surgery
World of medicine divided by 'wonder drug'
Multiple Sclerosis prevalence in New Zealand
Neuromyelitis optica: a demyelinating disease char...
Vitamin D - health perspectives &deficiencies
Lindsay's an author once again ... 32 years after ...
Rapid Formation of Extended Processes and Engageme...
The vitamin-D debate: how much is OK?
Cladribine Tablets for MS approved in Australia
Stem cell clinics: experts insist claims of cure-a...
Patients threaten to sue doctor over exploitative ...
Increased diffusivity in acute multiple sclerosis ...
Safety and efficacy of natalizumab in children wit...
The Cannabis spray that eases MS
Harry Potter Author Donates Millions to Multiple S...
Patients threaten to sue doctor over exploitative ...
The vitamin-D debate: how much is OK?
Cladribine Tablets for MS approved in Australia
Stem cell clinics: experts insist claims of cure-a...
Driving Simulator To Be Tested On Multiple Scleros...
Diffusion tensor imaging tractography in patients ...
Merck's Cladribine Tablets For Multiple Sclerosis ...
Relevance of cognitive deterioration in early rela...
Walk to Save Multiple Sclerosis (MS) Respite Centr...
Driving simulator to be tested on Multiple Scleros...
Multiple Sclerosis and Fibromyalgia
Merck's Cladribine Tablets For Multiple Sclerosis ...
Driving Simulator To Be Tested On Multiple Scleros...
Patients threaten to sue doctor over exploitative ...
Stem cell clinics: experts insist claims of cure-a...
Charities say sickness benefit reforms aren't work...
Medicinal cannabis review highlights dilemmas faci...
Impact of psychotherapy on insomnia symptoms in pa...
Patients claim a "postcode lottery" for drug
Variation in PCT funding of Sativex across the UK
Shaun McCarthy honoured with award for MS fundrais...
Submit your photos for a charity exhibition in Lon...
Putting patients and carers in the driving seat
You are here: Contact Us Call Us
 
Find us on Facebook

Donate to MSC

 

Newsletter

 
MSC's Newsletter


Receive HTML?

Call Us

Thursday, October 15 2009 00:33 Adam
E-mail Print PDF
More from this author:
Disclaimer
MSC Site Information > Legal
More Updated Disclaimer and Terms of Service
MSC Site Information > Legal
Writers wanted
MSC Site Information > Site News
Site Update 10/14/2009
MSC Site Information > Site News
Email forwarding
MSC Site Information > Site News
Related Articles:
MS Trust supports call for more research on LDN
From the Web > MedWorm: Multiple Sclerosis
Safety call over stem cell trips
From the Web > MS Trust Recent Story List
National MS Society Continues to Propel Research Forward end MS - Launches 2010 With Call for Research Grants to Pursue CCSVI
From the Web > MedWorm: Multiple Sclerosis
'Scrap MS drug scheme' call
From the Web > MedWorm: Multiple Sclerosis
Call to invest in specialist nurses
From the Web > MS Trust Recent Story List

Bible Gateway

 

Enter the Bible passage, keyword, or topic you want to find.



BibleGateway.com
Great church websites and effective ministry websites
 

Verse of the Day

 

Twitter Updates

 

My Twitter Updates

twitter Follow MSChristian on Twitter